Emerging Evidence on the Treatment of Obesity

Opinion
Video

In this episode of MEDcast, Diana Isaacs and Natalie Bellini interview Dr. Ken Fujioka, an endocrine specialist, to discuss practice guidelines on obesity treatment and the evolution of anti-obesity medications over the last decade.

1:20 Obesity-associated metabolic disturbances

5:37 When to start medication for obesity

8:28 Metabolic pathways leading to weight gain

13:19 Long-term impact of weight fluctuations

16:07 GLP-1 agonists for weight loss

20:26 Insurance coverage for anti-obesity medications (AOMs)

24:50 Combining lifestyle changes with AOMs

26:27 ‘Super-responders’ to GLP-1 agonist therapies

30:51 Non-responders to GLP-1 agonist therapies

37:28 Comprehensive approach to weight management

Recent Videos
A panel of 3 experts on dry eye
Brendon Neuen, MBBS, PhD | Credit: X.com
A panel of 3 experts on ocular diseases and conditions
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
© 2024 MJH Life Sciences

All rights reserved.